Real-time enrollment status for this chronic lymphocytic leukaemia or small lymphocytic lymphoma with unmutated ighv clinical trial
Current Status
Recruiting
Checked: September 8, 2026 at 7:54 PM UTC
| NCT Number | NCT07509151 |
| Recruiting Status | Recruiting |
| Condition | Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV |
| Phase | PHASE3 |
| Target Enrollment | 420 participants |
| Active Locations | 14 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | September 8, 2026 (19 hours ago) |
As of September 8, 2026: Clinical trial NCT07509151 is currently recruiting participants. This phase3 study for chronic lymphocytic leukaemia or small lymphocytic lymphoma with unmutated ighv is actively seeking new participants at 14 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07509151 is actively recruiting participants as of September 8, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07509151 was last updated 19 hours ago (September 8, 2026). HelloStudys verifies this status automatically.